NCT01140425View on ClinicalTrials.gov

Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Healthy
Interventions
DRUG

PF-00232798

600 mg oral solution once daily x 7 days

DRUG

PF-00232798

300 mg oral solution once daily x 7 days

DRUG

Placebo

Oral solution once daily x 7 days

DRUG

Moxifloxacin

400 mg tablet single dose

Trial Locations (1)

188770

Pfizer Investigational Site, Singapore

Sponsors

Lead Sponsor

Pfizer

Collaborators (1)

ViiV Healthcare
All Listed Sponsors
collaborator

ViiV Healthcare

INDUSTRY

lead

Pfizer

INDUSTRY